CELLO HEALTH ANNOUNCES THE FORMATION OF CELLO HEALTH BIOCONSULTING IN THE US

Cello Health announces the formation of Cello Health BioConsulting in the US.  Cello Health BioConsulting is a Strategic Management Consulting Firm focusing on Pharmaceuticals, Biotechnology and Medical Device companies in the United States. Cello Health BioConsulting will offer a unique set of services that focus on early product development, commercialization and business development support for small and mid-cap companies.

“Cello Health is  continuing to execute its global strategy of establishing itself as one of a small number of high quality, technically led advisers to the pharmaceutical and healthcare sector,” says Jon Bircher, Global CEO of Cello Health Consulting.

In line with the stated strategy, the international profile of Cello Health continues to grow rapidly. All of Cello Health’s core businesses are now represented in the U.S. market, which is by far the largest market for consulting and advisory services to the Pharmaceutical, Biotechnology and Healthcare industries.  

Julia Ralston, CEO of Cello Health, U.S., stated, “The U.S. continues to be a major thrust for Consulting with over 40% of our revenues generated here.  Cello Health is investing in the organic growth of its core operations across the world.”

Cello Health BioConsulting will have offices in Boston, New York City, Philadelphia, Chicago and San Francisco in order to recruit the best and brightest consultants and to ensure high quality service delivery to its clients.